Early research (Phase 1)Ended earlyNCT03871348
What this trial is testing
A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Who this might be right for
Metastatic Neoplasm
Sanofi 77